3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
9
Myelodysplastic Syndromes
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Multiple Myeloma
4
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Recurrence
1
Plasmablastic Lymphoma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Immunoglobulin Light-chain Amyloidosis
1
Hematologic Neoplasms
1
HIV Infections
1
Graft vs Host Disease
1
Ganglioneuroblastoma
1
Burkitt Lymphoma
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Biopsy
7
pembrolizumab
6
Doxorubicin
6
Cyclophosphamide
6
X-Rays
4
Radiation
4
Phantoms, Imaging
4
Radiotherapy
3
Nuclear Medicine Department, Hospital
3
Irinotecan
3
Ifosfamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pazopanib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
fludarabine
2
ensartinib
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Melphalan
×
30 days
×
Clear all
No trials found.